95 related articles for article (PubMed ID: 20811983)
1. Identification of novel substrates of MAP Kinase cascades using bioengineered kinases that uniquely utilize analogs of ATP to phosphorylate substrates.
Zheng H; Al-Ayoubi A; Eblen ST
Methods Mol Biol; 2010; 661():167-83. PubMed ID: 20811983
[TBL] [Abstract][Full Text] [Related]
2. Identifying specific kinase substrates through engineered kinases and ATP analogs.
Kumar NV; Eblen ST; Weber MJ
Methods; 2004 Apr; 32(4):389-97. PubMed ID: 15003601
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs.
Eblen ST; Kumar NV; Shah K; Henderson MJ; Watts CK; Shokat KM; Weber MJ
J Biol Chem; 2003 Apr; 278(17):14926-35. PubMed ID: 12594221
[TBL] [Abstract][Full Text] [Related]
4. Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation.
Gum RJ; Young PR
Biochem Biophys Res Commun; 1999 Dec; 266(1):284-9. PubMed ID: 10581204
[TBL] [Abstract][Full Text] [Related]
5. Direct phosphorylation of focal adhesion kinase by c-Src: evidence using a modified nucleotide pocket kinase and ATP analog.
Chaudhary A; Brugge JS; Cooper JA
Biochem Biophys Res Commun; 2002 Jun; 294(2):293-300. PubMed ID: 12051709
[TBL] [Abstract][Full Text] [Related]
6. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
7. A "molecular evolution" approach for isolation of intrinsically active (MEK-independent) MAP kinases.
Levin-Salomon V; Livnah O; Engelberg D
Methods Mol Biol; 2010; 661():257-72. PubMed ID: 20811988
[TBL] [Abstract][Full Text] [Related]
8. Phage-display evolution of tyrosine kinases with altered nucleotide specificity.
Ting AY; Witte K; Shah K; Kraybill B; Shokat KM; Schultz PG
Biopolymers; 2001; 60(3):220-8. PubMed ID: 11774228
[TBL] [Abstract][Full Text] [Related]
9. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
[TBL] [Abstract][Full Text] [Related]
10. Engineering a "methionine clamp" into Src family kinases enhances specificity toward unnatural ATP analogues.
Ulrich SM; Kenski DM; Shokat KM
Biochemistry; 2003 Jul; 42(26):7915-21. PubMed ID: 12834343
[TBL] [Abstract][Full Text] [Related]
11. Engineering Src family protein kinases with unnatural nucleotide specificity.
Liu Y; Shah K; Yang F; Witucki L; Shokat KM
Chem Biol; 1998 Feb; 5(2):91-101. PubMed ID: 9495830
[TBL] [Abstract][Full Text] [Related]
12. Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position.
Hindley AD; Park S; Wang L; Shah K; Wang Y; Hu X; Shokat KM; Kolch W; Sedivy JM; Yeung KC
FEBS Lett; 2004 Jan; 556(1-3):26-34. PubMed ID: 14706820
[TBL] [Abstract][Full Text] [Related]
13. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
Crowe DL; Shemirani B
Anticancer Res; 2000; 20(5A):2945-9. PubMed ID: 11062705
[TBL] [Abstract][Full Text] [Related]
15. A novel mitogen-activated protein kinase gene in maize (Zea mays), ZmMPK3, is involved in response to diverse environmental cues.
Wang J; Ding H; Zhang A; Ma F; Cao J; Jiang M
J Integr Plant Biol; 2010 May; 52(5):442-52. PubMed ID: 20537040
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based identification of protein kinase substrates utilizing engineered kinases and thiophosphate labeling.
Chi Y; Clurman BE
Curr Protoc Chem Biol; 2010 Dec; 2(4):219-34. PubMed ID: 23839977
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of a traceable protein kinase Calpha.
Abeyweera TP; Rotenberg SA
Biochemistry; 2007 Mar; 46(9):2364-70. PubMed ID: 17279776
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor scaffolds as new allele specific kinase substrates.
Kraybill BC; Elkin LL; Blethrow JD; Morgan DO; Shokat KM
J Am Chem Soc; 2002 Oct; 124(41):12118-28. PubMed ID: 12371851
[TBL] [Abstract][Full Text] [Related]
19. An ATP analog-sensitive version of the tomato cell death suppressor protein kinase Adi3 for use in substrate identification.
Dittrich AC; Devarenne TP
Biochim Biophys Acta; 2012 Feb; 1824(2):269-73. PubMed ID: 22027266
[TBL] [Abstract][Full Text] [Related]
20. Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3.
Carlson SM; Chouinard CR; Labadorf A; Lam CJ; Schmelzle K; Fraenkel E; White FM
Sci Signal; 2011 Oct; 4(196):rs11. PubMed ID: 22028470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
